CINXE.COM
AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial
<!DOCTYPE html> <html lang="en"> <head> <!-- Google Tag Manager --> <script>(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-W9C8F5F');</script> <!-- End Google Tag Manager --> <meta charset="UTF-8"> <title>AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="theme-color" content="#FFF"> <meta name="author" content=""> <meta name="google-site-verification" content="bD4tV4Sl-EwlSwu4w1alwBUpBtTV_kAj0pkGjAarY-w"> <meta name="yandex-verification" content="52377bb9620367bb"> <meta itemprop="url" content="https://manufacturingchemist.com/"> <meta name="keywords" content=""> <meta name="description" content="The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously"> <link rel="icon" type="image/ico" href="/favicon.ico"> <link rel="canonical" href="https://manufacturingchemist.com/astrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints" /> <meta property="og:url" content="https://manufacturingchemist.com/astrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints"> <meta property="og:title" content="AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial"> <meta property="og:description" content="The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously"> <meta property="og:image" content="/article-image-alias/astrazeneca-and-amgen-s-tezspire-meets-primary.jpg"> <meta property="og:image:alt" content="AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="manchempharma"> <meta name="twitter:creator" content="@hpcimedia"> <meta name="twitter:title" content="AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial"> <meta name="twitter:description" content="The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously"> <meta name="twitter:image" content="/article-image-alias/astrazeneca-and-amgen-s-tezspire-meets-primary.jpg"> <link href="https://cdn.jsdelivr.net/npm/remixicon@3.2.0/fonts/remixicon.css" rel="stylesheet"> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin> <link href="https://fonts.googleapis.com/css2?family=Raleway:ital,wght@0,300;0,400;0,700;1,400;1,900&display=swap" rel="stylesheet"> <link rel="stylesheet" href="/build/app_manufacturingchemist.com.f7c17d27.css"> <script src="/build/runtime.ced75ccf.js" defer></script><script src="/build/app_manufacturingchemist.com.47c00b06.js" defer></script> <script> document.addEventListener('DOMContentLoaded', function () { const cachedAdResponses = []; const lazyAdViewObserver = new IntersectionObserver(handleAdView, { threshold: [0.5] }); const lazyImageObserver = new IntersectionObserver(handleLazyImages, { threshold: 0.05 }); const lazyCSSBGImageObserver = new IntersectionObserver(handleLazyBGImages, { threshold: 0.05 }); // Initialize reloadAds(); observeImagesAndBG(); // Event listeners window.addEventListener('resize', reloadAds); document.querySelector('.nav-toggler').addEventListener('click', toggleNav); document.querySelector('.search-dropdown .close-btn').addEventListener('click', closeSearchDropdown); document.querySelectorAll('.has-sub a').forEach(element => { element.addEventListener('click', () => toggleSubMenu(element)); }); // Functions function reloadAds() { document.querySelectorAll('.ads > a').forEach(generateAdViewEvent); } function handleAdView(entries) { entries.forEach(entry => { if (entry.isIntersecting && entry.intersectionRatio > 0.5) { lazyAdViewObserver.unobserve(entry.target); confirmAdViewEvent(entry.target); } }); } function handleLazyImages(entries) { entries.forEach(entry => { if (entry.isIntersecting) { entry.target.childNodes.forEach(replacePictureSourceAndImgSets); lazyImageObserver.unobserve(entry.target); } }); } function handleLazyBGImages(entries) { entries.forEach(entry => { if (entry.isIntersecting) { const realImageUrl = entry.target.getAttribute('data-bg'); entry.target.style.backgroundImage = `url(${realImageUrl})`; lazyCSSBGImageObserver.unobserve(entry.target); } }); } function toggleNav() { const mainNavWrapper = document.querySelector('.main-nav-wrapper'); mainNavWrapper.classList.toggle('open'); this.classList.toggle('toggle-active'); } function closeSearchDropdown() { document.querySelector('.search-dropdown').classList.remove('open'); } function toggleSubMenu(element) { const parent = element.parentElement; const isOpen = parent.classList.toggle('open'); if (isOpen) { document.querySelectorAll('.has-sub').forEach(subElement => { if (subElement !== parent) subElement.classList.remove('open'); }); } } function generateAdViewEvent(element) { if (element.hasAttribute('data-is-loaded') || !element.dataset.url || !element.hasAttribute('data-is-mobile')) { return; } const uniqueId = element.getAttribute('data-unique-id'); if (uniqueId && cachedAdResponses[uniqueId]) { return; } if (element.hasAttribute('data-is-mobile')) { if ('1' === element.getAttribute('data-is-mobile') && !window.matchMedia("(max-width: 768px)").matches || '0' === element.getAttribute('data-is-mobile') && window.matchMedia("(max-width: 768px)").matches) { return; } } const xhr = new XMLHttpRequest(); xhr.onreadystatechange = function () { if (this.readyState === 4 && this.status === 200) { const data = JSON.parse(this.responseText); element.href = data.redirect_url; element.dataset.confirmUrl = data.confirm_url; lazyAdViewObserver.observe(element); element.setAttribute('data-is-loaded', 'true'); cachedAdResponses[uniqueId] = element; } }; xhr.open('POST', element.dataset.url, true); // ASynchronous request xhr.send(); } function confirmAdViewEvent(element) { if (element.dataset.confirmUrl) { const xhr = new XMLHttpRequest(); xhr.open('POST', element.dataset.confirmUrl, true); xhr.send(); } } function replacePictureSourceAndImgSets(element) { if (element.tagName === 'SOURCE') { element.srcset = element.dataset.srcset; delete element.dataset.srcset; } else if (element.tagName === 'IMG' && element.dataset.src) { element.src = element.dataset.src; delete element.dataset.src; } } function observeImagesAndBG() { document.querySelectorAll('picture').forEach(element => lazyImageObserver.observe(element)); document.querySelectorAll('[data-bg]').forEach(img => lazyCSSBGImageObserver.observe(img)); } }); </script> </head> <body> <!-- Google Tag Manager (noscript) --> <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W9C8F5F" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript> <!-- End Google Tag Manager (noscript) --> <header class="header"> <div class="width-container wide"> <div class="padding"> <div class="header-top flex-mob-up align-items-center-mob-up justify-content-space-between-mob-up"> <a href="https://manufacturingchemist.com/" class="logo"> <img alt="Manufacturing Chemist" src="/images/logo.svg"/> </a> </div> <div class="header-bottom"> <nav class="main-nav-wrapper flex-sm-up align-items-center-sm-up justify-content-space-between-sm-up"> <button class="nav-toggler hide-show-sm-down" type="button" data-toggle="collapse" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"><span></span></span> </button> <ul class="main-nav"> <li><a href="/">Home</a></li> <li class="has-sub"><a href="#">Categories</a> <div class="dropdown wide"> <ul> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Ingredients" href="/tag/ingredients"><span itemprop="name">Ingredients</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Analysis" href="/tag/analysis"><span itemprop="name">Analysis</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Manufacturing" href="/tag/manufacturing"><span itemprop="name">Manufacturing</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Finance" href="/tag/finance"><span itemprop="name">Finance</span> <meta itemprop="position" content="1"> </a> </li> </ul> <ul> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Regulatory" href="/tag/regulatory"><span itemprop="name">Regulatory</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Drug Delivery" href="/tag/drug-delivery"><span itemprop="name">Drug Delivery</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Research & Development" href="/tag/research-and-development"><span itemprop="name">Research & Development</span> <meta itemprop="position" content="1"> </a> </li> <li itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"> <a itemprop="item" title="Sustainability" href="/tag/sustainability"><span itemprop="name">Sustainability</span> <meta itemprop="position" content="1"> </a> </li> </ul> </div> </li> <li> <a title="Pharma 5.0" href="/tag/pharma">Pharma 5.0</a> </li> <li><a href="/jobs">Company News</a></li> <li><a href="/events">Events</a></li> <li><a title="Directory" href="/directory">Directory</a></li> <li class="has-sub search-dropdown"><a href="#"><i class="ri-search-line" aria-hidden="true" focusable="false"></i><span class="visually-hidden">Search</span></a> <div class="dropdown"> <ul> <li itemscope itemtype="https://schema.org/WebSite"> <meta itemprop="url" content="https://manufacturingchemist.com/"/> <form class="colourway02 transparent-background" method="get" action="/search" itemprop="potentialAction" itemscope itemtype="https://schema.org/SearchAction"> <div class="input-group"> <input type="search" id="q" name="q" data-autocomplete-url="/ajax" data-autocomplete-field="title" itemprop="query-input" placeholder="Enter search term" class="js-autocomplete form-control ui-autocomplete-input" aria-describedby="search-addon" autocomplete="off"> <meta itemprop="target" content="https://manufacturingchemist.com/search?q={q}"> <button class="icon-btn" type="submit" id="search-addon"> <i aria-hidden="true" focusable="false" class="ri-search-line ri-xl"></i> </button> </div> <span class="close-btn"><i aria-hidden="true" focusable="false" class="ri-close-line ri-xl"></i>Close search</span> </form> </li> </ul> </div> </ul> <ul class="subscriber-nav logged-out"> <li class="subscribe-link"><a href="https://hpcimedia.com/service/signup-campaign/MCSub">Subscribe <div class="locked-story"> <div class="locked-story-inner"><i aria-hidden="true" focusable="false" class="ri-lock-line"></i></div> </div> </a></li> <li class="has-sub subscriber-dropdown"><a href="#">Login</a> <div class="dropdown"> <ul> <li> <form name="custom_user_authentication_form" method="post" action="/authentication" class="colourway02 transparent-background"> <div class="icon-input-wrapper"> <i class="ri-mail-line ri-xl" aria-hidden="true" focusable="false"><span class="visually-hidden">Password</span></i> <input type="email" id="custom_user_authentication_form_email" name="custom_user_authentication_form[email]" required="required" placeholder="Email" class="form-control" /> </div> <div class="icon-input-wrapper"> <i class="ri-key-line ri-xl" aria-hidden="true" focusable="false"><span class="visually-hidden">Password</span></i> <input type="password" id="custom_user_authentication_form_password" name="custom_user_authentication_form[password]" required="required" placeholder="Password" class="form-control" /> </div> <div class="checkbox-wrapper"> <div class="mb-3"><div class="form-check"><input type="checkbox" id="custom_user_authentication_form__remember_me" name="custom_user_authentication_form[_remember_me]" class="form-check-input form-check-input" value="1" /> <label class="form-check-label form-check-label" for="custom_user_authentication_form__remember_me">Remember me</label></div></div> </div> <input type="submit" class="btn btn-sm btn-dark m-2 hovered-shadow" value="Sign In"> <a class="forgot-password-link-wrapper" href="mailto:subscriptions@hpcimedia.com?subject=Forgot password&body=Hello, I forgot my password">Forgot password?</a> <span class="close-btn"> <i aria-hidden="true" focusable="false" class="ri-close-line ri-xl"></i>Close login form</span> </form> </li> </ul> </div> </li> </ul> <script> document.addEventListener("DOMContentLoaded", function () { document.querySelector('.subscriber-dropdown .close-btn').addEventListener('click', function () { document.querySelector('.subscriber-dropdown').classList.remove('open'); }); }); </script> </nav> </div> </div> </div> </header> <nav class="breadcrumb"> <div class="width-container wide"> <ul id="wo-breadcrumbs" class="breadcrumb" itemscope itemtype="http://schema.org/BreadcrumbList"> <li><a href="/"><i class="ri-home-5-line" aria-hidden="true" focusable="false"></i><span class="visually-hidden">Home</span></a> </li> <li itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/tag/drug-delivery" itemprop="item"> <span itemprop="name" class="current">Drug Delivery</span> </a> <meta itemprop="position" content="1"/> </li> <li itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <span itemprop="name" class="current">AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial</span> <meta itemprop="item" content="/astrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints"/> <meta itemprop="position" content="2"/> </li> </ul> </div> </nav> <div class="main"> <header class="article-header"> <div class="width-container wide"> <div class="padding"> <div class="grid flex-mob-row"> <div class="column06 flex-sm-up align-items-center-sm-up mob-order02"> <div class="article-intro"> <h1>AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial </h1> <byline> Published: 11-Nov-2024 </byline> <byline class="tags-byline"> <div class="tags-background"> <a href="/tag/drug-delivery">Drug Delivery</a> <a href="/tag/research-and-development">Research & Development</a> </div> </byline> <p>The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously</p> </div> </div> <div class="column06 mob-order01"> <div class="featured-image"> <div class="featured-image-inner article-featured-image " data-bg="/article-image-alias/astrazeneca-and-amgen-s-tezspire-meets-primary.jpg"> </div> </div> </div> </div> </div> </div> </header> <div class="width-container"> <div class="padding"> <div class="article-wrapper flex-md-up justify-content-space-between-md-up"> <article class="article"> <p></p> <p>AstraZeneca and Amgen's Tezspire has met both primary endpoints in the WAYPOINT Phase III clinical trial.</p> <p>The drug can be administered subcutaneously, and is suitable for use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).</p> <p>During the study, it was found that Tezspire could significantly reduce the size of nasal polyps and diminish congestion when compared to placebo.</p> <p>The randomised, double-blind trial evaluated both the efficacy and safety of Tezspire in adults with severe CRSwNP, who were all symptomatic despite receiving intranasal corticosteroids. </p> <p>During the trial period, the injectable also exhibited a similar safety and tolerability profile to previous findings. </p> <p>AstraZeneca has stated that full results will be shared with regulatory authorities in due course.</p> <p>Dr Joseph Han, Vice Chair of Rhinology & Endoscopic Sinus and Skull Base Surgery, and Allergy, Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, US, and co-primary investigator in the trial, said: “Chronic rhinosinusitis with nasal polyps negatively impact patients’ daily lives with obstructions leading to disturbances in smell, taste and sleep as well as pain and fatigue."</p> <p>"The impressive data from the WAYPOINT trial demonstrate tezepelumab’s potential as a new treatment for patients whose lives are disrupted by this debilitating disease.”</p> <p>Sharon Barr, Executive Vice President, BioPharmaceuticals R&D said: “We are excited by the positive results from the Phase III WAYPOINT trial, which show that patients with nasal polyps strongly benefitted from treatment with tezepelumab."</p> <p>"These results reinforce that tezepelumab’s first-in-class mode of action, targeting TSLP at the top of the inflammatory cascade, effectively addresses the multiple drivers of epithelial-driven inflammatory diseases.”</p> <p>Dr Brian Lipworth, Professor of Allergy and Pulmonology, Scottish Centre for Respiratory Research, and Tayside Rhinology Ear, Nose and Throat Clinic, Ninewells Hospital University of Dundee in Scotland, UK, and co-primary investigator in the trial, concluded: “Patients diagnosed with nasal polyps continue to experience significant burden including repeat surgeries and frequent treatment with high doses of oral corticosteroids, which are associated with serious systemic side effects. The tezepelumab data are clinically meaningful and offer patients with nasal polyps hope for a potential new treatment option that may reduce the burden on patients and healthcare systems.”<br /> <br /> Tezspire is currently approved for the treatment of severe asthma in the US, EU, Japan, and nearly 60 countries across the globe.2-5 It is approved as a single-use pre-filled syringe and auto-injector for self-administration in the US and EU.</p> <section class="article-footer"> <div class="social-share-nav"> <ul> <li> <a href="http://twitter.com/share?text=AstraZeneca%20and%20Amgen%27s%20Tezspire%20meets%20primary%20endpoints%20in%20Phase%20III%20trial&url=https%3A%2F%2Fmanufacturingchemist.com%2Fastrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints" target="_blank" title="Share on X"> <i aria-hidden="true" class="twitter-share-button circle-icon large x-icon"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"> <path d="M8 2H1L9.26086 13.0145L1.44995 21.9999H4.09998L10.4883 14.651L16 22H23L14.3917 10.5223L21.8001 2H19.1501L13.1643 8.88578L8 2ZM17 20L5 4H7L19 20H17Z"></path> </svg> </i> <span class="visually-hidden">Share on X</span> </a> </li> <li> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https://manufacturingchemist.com/astrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints&title=AstraZeneca%20and%20Amgen%27s%20Tezspire%20meets%20primary%20endpoints%20in%20Phase%20III%20trial&summary=The%20Phase%20III%20WAYPOINT%20trial%20demonstrated%20Tezspire%27s%20ability%20to%20reduce%20nasal%20polyps%20and%20congestion%20compared%20to%20placebo%20when%20administered%20subcutaneously&source=https%3A%2F%2Fmanufacturingchemist.com%2Fastrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints" target="_blank" title="Share on LinkedIn"> <i aria-hidden="true" class="circle-icon large ri-linkedin-fill"></i> <span class="visually-hidden">Share on LinkedIn</span> </a> </li> <li> <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fmanufacturingchemist.com%2Fastrazeneca-amgen-tezspire-subcutaneous-rhinosinusitis-meets-primary-endpoints" target="_blank" title="Share on Facebook"> <i aria-hidden="true" class="circle-icon large ri-facebook-fill"></i> <span class="visually-hidden">Share on Facebook</span> </a> </li> </ul> </div> <div class="block block-companies large"> <div class="block-inner"> <div class="block-grid"> </div> <div class="seeAlso"> <ul> <li>Companies:</li> <li> AstraZeneca </li> </ul> </div> <a title="Directory" href="/directory"><span class="read-more arrow-link">See more</span></a> </div> </div> </section> </article> <sidebar class="sidebar"> <div class="block tip-trigger"> <h3 class="has-icon block-header"><i class=" ri-heart-line" aria-hidden="true" focusable="false"></i>You may also like</h3> <div class="block-inner"> <a href="/tag/regulatory" class="category-label">Regulatory</a> <a href="/astrazeneca-ionis-wainzua-amyloidosis-drug-recommended-for-eu-approval"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/astrazeneca-s-wainzua-recommended-for-eu-approval.jpg"></div> </div> <h3>AstraZeneca's Wainzua recommended for EU approval to treat amyloidosis</h3> <span class="read-more arrow-link">Read more</span> <div class="tooltip">The neuropathy drug was developed in tandem with Ionis, and has been shown to reduce neuropathy and increase quality of life in the Phase III NEURO-TTransform trial </div> </a> </div> </div> <div class="block block-top-five"> <h3 class="has-icon block-header"><i class=" ri-arrow-right-up-line" aria-hidden="true" focusable="false"></i>Trending Articles</h3> <div class="block-inner"> <ol> <li> <div class="tip-trigger"> <a href="/cm-scientific-acquires-scientific-equipment-specialist-radison-services"> C&M Scientific acquires scientific equipment specialist, Radison Services <span class="tooltip">Through this acquisition, the service arm of the Scientific Laboratory Supplies Group will expand its reach across the UK and Ireland </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/get-ahead-in-the-pharmaceutical-industry-with-a"> Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription <span class="tooltip">With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/selkirk-pharma-launches-fill-finish-service-clinical-trial-supply"> Selkirk Pharma launches fill/finish service for efficient clinical trial supply <span class="tooltip">The flexible ClinFAST service prioritises small-scale batches (under 10,000 vials per batch) for clinical trials, reducing production wait times for biotech and pharma companies </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/ethris-cepi-spray-dried-rna-vaccine-development-grant"> Ethris bags $5m to develop stable spray-dried RNA vaccines <span class="tooltip">The grant will support Ethris' R&D efforts, which are focused on developing room temperature-stable RNA vaccines suitable for mucosal delivery </span> </a> </div> </li> <li> <div class="tip-trigger"> <a href="/recipharm-expands-gmp-aseptic-filling-capabilities-wasserburg-germany"> Recipharm expands aseptic filling capabilities at Wasserburg, Germany site <span class="tooltip">The novel system facilitates the cost-effective, GMP-compliant aseptic manufacture of PFSs, syringes and vials at a small scale, delivering between 500 to 50,000 units per batch </span> </a> </div> </li> </ol> </div> </div> <div class="block block-event"> <h3 class="has-icon block-header"><i class=" ri-calendar-close-line" aria-hidden="true" focusable="false"></i>Upcoming event</h3> <div class="block-inner"> <a href="/pharma-packaging-and-labelling-forum" class="block-inner event-block"> <span> <i class="ri-calendar-event-line ri-2x"></i> <h3>Pharma Packaging and Labelling Forum</h3> <byline>5–6 March 2025 | Conference | San Diego, US</byline> </span> </a> <a href="/events"><span class="read-more arrow-link">See all</span></a> </div> </div> </sidebar> </div> </div> </div> <script> document.addEventListener("DOMContentLoaded", function () { // Replace in blockquote elements document.querySelectorAll("blockquote").forEach(function(blockquote) { blockquote.innerHTML = blockquote.innerHTML.replace(/ /g, ''); }); /* FitVids 1.1 - Vanilla JS version */ (function () { function fitVids(selector, options = {}) { const settings = { customSelector: options.customSelector || null, ignore: options.ignore || null, }; if (!document.getElementById("fit-vids-style")) { const css = ` .fluid-width-video-wrapper { width: 100%; position: relative; padding: 0; } .fluid-width-video-wrapper iframe, .fluid-width-video-wrapper object, .fluid-width-video-wrapper embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; } `; const style = document.createElement("style"); style.id = "fit-vids-style"; style.innerHTML = css; document.head.appendChild(style); } const selectors = [ 'iframe[src*="player.vimeo.com"]', 'iframe[src*="youtube.com"]', 'iframe[src*="youtube-nocookie.com"]', 'iframe[src*="kickstarter.com"][src*="video.html"]', 'object', 'embed', ]; if (settings.customSelector) { selectors.push(settings.customSelector); } const ignoreList = settings.ignore ? `.fitvidsignore, ${settings.ignore}` : ".fitvidsignore"; document.querySelectorAll(selector).forEach(function(element) { const videos = element.querySelectorAll(selectors.join(",")); videos.forEach(function(video) { if (video.closest(ignoreList)) return; if (video.tagName.toLowerCase() === "embed" && video.closest("object")) return; if (video.closest(".fluid-width-video-wrapper")) return; let height = video.tagName.toLowerCase() === "object" || !isNaN(parseInt(video.height)) ? parseInt(video.height) : video.clientHeight; let width = !isNaN(parseInt(video.width)) ? parseInt(video.width) : video.clientWidth; let aspectRatio = height / width; const wrapper = document.createElement("div"); wrapper.className = "fluid-width-video-wrapper"; wrapper.style.paddingTop = (aspectRatio * 100) + "%"; video.parentNode.insertBefore(wrapper, video); wrapper.appendChild(video); video.removeAttribute("height"); video.removeAttribute("width"); }); }); } // Initialize FitVids on ".main" selector fitVids(".main"); // Script for ad insertion based on article length and children count const regex = /(<([^>]+)>|\r\n|\n|\r)/ig; const primaryAd = document.querySelector('.mobile-ad-01')?.innerHTML || ''; const secondaryAd = document.querySelector('.mobile-ad-02')?.innerHTML || ''; const tertiaryAd = document.querySelector('.mobile-ad-03')?.innerHTML || ''; const articleHeaderHeight = document.querySelector('.header')?.offsetHeight || 0; const articleContentHeight = document.querySelector('.article-header')?.offsetHeight + document.querySelector('.article')?.offsetHeight || 0; const article = document.querySelector('.article')?.textContent || ''; const articleChildrenCount = document.querySelector('.article')?.children.length || 0; const articleCharCount = article.replace(regex, "").length; let childCount = 1; if (articleCharCount > 2000 && articleChildrenCount >= 10) { Array.from(document.querySelector('.article').children).forEach(function(para) { const position = para.getBoundingClientRect().top; if (childCount === 3) para.insertAdjacentHTML("afterend", primaryAd); if (childCount === 7) para.insertAdjacentHTML("afterend", secondaryAd); if (childCount === articleChildrenCount) para.insertAdjacentHTML("beforebegin", tertiaryAd); childCount++; }); } })(); }); </script> <section class="you-may-also-like"> <h2 class="span-header"><span>You may also like</span></h2> <div class="width-container wide"> <div class="padding"> <div class="fixed-grid"> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/regulatory" class="category-label">Regulatory</a> <a href="/astrazeneca-ionis-wainzua-amyloidosis-drug-recommended-for-eu-approval"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/astrazeneca-s-wainzua-recommended-for-eu-approval.jpg"></div> </div> <h3>AstraZeneca's Wainzua recommended for EU approval to treat amyloidosis</h3> <div class="tooltip above">The neuropathy drug was developed in tandem with Ionis, and has been shown to reduce neuropathy and increase quality of life in the Phase III NEURO-TTransform trial </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/research-and-development" class="category-label">Research & Development</a> <a href="/astrazeneca-airsupra-phase-iii-primary-endpoint-met"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/astrazeneca-s-asthma-targeting-airsupra-meets-primary-endpoint.jpg"></div> </div> <h3>AstraZeneca's asthma-targeting Airsupra meets primary endpoint in Phase III trial</h3> <div class="tooltip above">The inhaled therapeutic has proven effective in reducing the risk of severe asthma attacks in patients with intermittent or persistent asthma </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/drug-delivery" class="category-label">Drug Delivery</a> <a href="/Aptamer-AstraZeneca-siRNA-fibrotic-liver-delivery-vehicle"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/aptamer-and-astrazeneca-to-determine-the.jpg"></div> </div> <h3>Aptamer and AstraZeneca to determine the efficacy of targeted siRNA delivery vehicle</h3> <div class="tooltip above">AstraZeneca is providing Aptamer with siRNAs to test if its Optima fibrotic liver technology can successfully facilitate the delivery and cell integration of therapeutic RNA </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/research-and-development" class="category-label">Research & Development</a> <a href="/BenevolentAI-AstraZeneca-lupus-target-discovery-AI"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/benevolentai-and-astrazeneca-collaboration-leads-to.jpg"></div> </div> <h3>BenevolentAI and AstraZeneca collaboration leads to novel lupus target discovery</h3> <div class="tooltip above">The novel target will be added to AstraZeneca's drug development pipeline for lupus, an autoimmune disease with significant unmet needs in the patient population </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/research-and-development" class="category-label">Research & Development</a> <a href="/AstraZeneca-Amgen-ATS-2024-tezepelumab-COPD"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/astrazeneca-presents-data-at-ats-2024.jpg"></div> </div> <h3>AstraZeneca presents data at ATS 2024 highlighting tezepelumab’s potential in treating COPD</h3> <div class="tooltip above">Late-breaking results from the Phase IIa COURSE trial provide insight into tezepelumab's impact on COPD exacerbations in patients with a broad range of eosinophil levels </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/research-and-development" class="category-label">Research & Development</a> <a href="/BenevolentAI-AstraZeneca-heart-failure-target"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/benevolentai-and-astrazeneca-collaboration-finds-novel.jpg"></div> </div> <h3>BenevolentAI and AstraZeneca collaboration finds novel heart failure target</h3> <div class="tooltip above">The heart failure target was discovered through an AI platform, with AstraZeneca then experimentally validating its clinical potential </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block half-mob"> <div class="block-inner tip-trigger"> <a href="/tag/research-and-development" class="category-label">Research & Development</a> <a href="/covid-19-INFORM-immunocompromised-study-astrazeneca"> <div class="featured-image"> <div class="featured-image-inner" data-bg="/article-image-alias/covid-19-still-a-significant-risk-for.jpg"></div> </div> <h3>COVID-19 still a significant risk for the immunocompromised, study finds</h3> <div class="tooltip above">AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme </div> <!--span class="read-more arrow-link">Read more</span--> </a> </div> </div> <div class="block height01"> <a href="https://hpcimedia.com/service/signup-campaign/MCSub" class="btn">Subscribe now</a> </div> </div> </div> </div> </section> </div> <footer class="footer colourway02"> <div class="footer-section"> <div class="width-container wide"> <div class="padding"> <div class="grid"> <div class="column08 column-border"> <div class="block large"> <h2 class="headline">Become a <strong>Subscriber</strong></h2> <p></p> <a href="https://hpcimedia.com/service/signup-campaign/MCSub" class="btn submit-btn">Subscribe now</a> <small class="already-subscriber">Already a subscriber? <a href="/authentication">Sign in here.</a> </small> <a title="Subscribe" href="/get-ahead-in-the-pharmaceutical-industry-with-a" class="read-more arrow-link">Find out more</a> </div> </div> <div class="column04 flex-sm-up align-items-center-sm-up"> <div class="block"> <h3 class="has-icon block-header"><i aria-hidden="true" focusable="false" class="ri-mail-line"></i>Get our newsletter</h3> <div class="input-group"> <input type="email" placeholder="Enter your email address" required> <button class="icon-btn" type="submit" id="search-addon" onclick="location.href='https://hpcimedia.com/service/signup-campaign/MCeNews?email=' + this.previousElementSibling.value"> <i class="ri-arrow-right-line ri-xl"></i> </button> </div> <h3 class="has-icon block-header"><i aria-hidden="true" focusable="false" class="ri-share-line"></i>Follow us</h3> <div class="social-nav large"> <ul> <li> <a href="https://twitter.com/manchempharma" target="blank" title="Follow Manufacturing Chemist on X"><i aria-hidden="true" focusable="false" class="x-icon ri-2x"> <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"> <path d="M8 2H1L9.26086 13.0145L1.44995 21.9999H4.09998L10.4883 14.651L16 22H23L14.3917 10.5223L21.8001 2H19.1501L13.1643 8.88578L8 2ZM17 20L5 4H7L19 20H17Z"></path> </svg> </i><span class="visually-hidden">X</span></a></li> <li> <a href="https://www.linkedin.com/showcase/manufacturing-chemist/" target="blank" title="Follow Manufacturing Chemist on LinkedIn"><i aria-hidden="true" focusable="false" class="ri-linkedin-fill ri-2x"></i><span class="visually-hidden">LinkedIn</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </div> <div class="footer-section"> <div class="width-container wide"> <div class="padding"> <div class="grid"> <div class="column04"> <div class="logo"><img src="/images/logo.svg"/></div> </div> <div class="column08"> <div class="footer-links-wrapper grid"> <div class="column04"> <ul class="footer-links"> <li> <a href="https://hpcimedia.com/manufacturing-chemist/">About Manufacturing Chemist</a> </li> <li><a href="https://hpcimedia.com/">About HPCi Media</a></li> <li> <a href="https://hpcimedia.com/service/signup-campaign/MCeNews">Newsletter sign up</a></li> <li><a href="https://hpcimedia.com/">Contact Us</a></li> </ul> </div> <div class="column04"> <ul class="footer-links"> <li><a href="https://hpcimedia.com/manufacturing-chemist/">Advertise</a></li> <li><a href="https://hpcimedia.com/tsandcs/">Terms and Conditions</a></li> <li><a href="https://hpcimedia.com/privacy-policy/">Privacy</a></li> </ul> </div> <div class="column04"> <small>© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company</small> <small>Registered office address: <br>One Anchorage Avenue, <br> Shrewsbury Business Park, <br>Shrewsbury, <br>SY2 6FG, UK.</small> </div> </div> </div> </div> </div> </div> </div> </footer></body> </html>